This summary covers the issue of September 7, 2006. Featured are articles on DNA repair by ERCC1 in non–small-cell lung cancer and adjuvant chemotherapy, soluble endoglin and other circulating antiangiogenic factors in preeclampsia, enoxaparin versus unfractionated heparin in elective PCI, cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412; review articles on social anxiety disorder and on oncogene-induced cell senescence; a clinical problem-solving article describing more than meets the eye; and Perspective articles on T-cell costimulation, on going beyond disease to address disability, and on learning clinical judgment as a medical student.
Thursday, September 7, 2006
New England Journal of Medicine Audio Summary for September 7, 2006
From the NEJM: